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Abstract: Contemporary reports on the bioactive oligomers derived from natural aliphatic co-polyesters 
(PHA) and their synthetic analogues, formed through anionic ring-opening polymerization (ROP) of 
β-substituted β-lactones are presented. Synthetic routes for such oligomers, developed mostly by Polish 
authors, are discussed. The described approaches enable design of novel biodegradable and bioactive 
oligomers for diverse applications in medicine, cosmetic industry and agrochemistry. 
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Otrzymywanie bioaktywnych oligomerów z naturalnych biopoliestrów i ich 
syntetycznych analogów
Streszczenie: Przedstawiono przegląd aktualnych wyników badań dotyczących bioaktywnych oligo-
merów otrzymywanych z naturalnych alifatycznych ko-poliestrów (PHA) oraz ich syntetycznych ana-
logów, uzyskanych na drodze anionowej polimeryzacji z otwarciem pierścienia (ROP) β-podstawionych 
β-laktonów. Omówiono ścieżki syntezy tych oligomerów opracowane głównie przez polskich badaczy. 
Zaprezentowane metody umożliwiają projektowanie nowych biodegradowalnych, a zarazem bioak-
tywnych oligomerów mogących znaleźć różnorodne zastosowania w medycynie, przemyśle kosme-
tycznym i agrochemii. 
Słowa kluczowe: poliester alifatyczny, anionowa polimeryzacja, oligomer bioaktywny, β-podstawiony 
β-lakton. 
Polyhydroxyalkanoates (PHA) are a group of biopoly-
esters that have a wide range of applications. Extensive 
progress has been made in our understanding of PHA 
biosynthesis, and currently, it is possible to engineer bac-
terial strains to produce PHA with desired properties. 
Overview on the current carbon sources used for PHA 
production and the methods used to transform these 
sources into fermentable forms has been published re-
cently [1]. It should be mentioned, that among various 
carbons sources we report also on the ability of bacteria 
to produce PHA from polyethylene via oxidized polyethy-
lene wax as a novel carbon source [2]. The studies are also 
carried out by other laboratories on production of high 
levels of PHA in tobacco plants [3]. 
PHA polymers are thermoplastic and depending on 
their chemical composition they may differ in their prop-
erties. Blending of PHA with other biodegradable poly-
mers tunes properties of polymeric materials suitable for 
packaging applications. Current trends in the packaging 
industry are towards compostable bio-based lighter weight 
materials for reduction of raw material use, transportation 
costs, minimizing the amount of waste and it may be ex-
pected that interest in sustainable materials combined with 
barrier improving additives will continue to growth [4]. 
OLIGOMERS FROM NATURAL 
POLYHYDROXYALKANOATES 
PHA due to their in vivo and in vitro biodegradation as 
well as cell and tissue compatibility can be used for medi-
cal applications, especially as implants, including heart 
valve tissue engineering, vascular tissue engineering, 
bone tissue engineering, cartilage tissue engineering as 
well as nerve conduit tissue engineering. Moreover, PHA 
implants were found not to cause carcinogenesis during 
long-term implantation. Chemical modifications of PHA 
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in order to introduce functional groups, that cannot be 
easily achieved by bioconversion processes, are a valu-
able challenge since chemically modified PHA can be 
utilized as multifunctional biomaterials [5]. 
PHA oligomers contained unsaturated end groups 
PHA can be reacted with a carbonate salts, yielding 
oligomers possessing a controlled molecular weight, 
which can be modulated in view of the specific appli-
cation for which the products are intended [6–8]. The 
degradation reaction can be carried out as a continuous 
process, e.g., by means of an extruder, with outstanding 
advantages for an industrial applications. The obtained 
oligomers are terminated by unsaturated and carboxyl-
ate end groups [as revealed by electrospray ionization 
mass spectrometry (ESI-MSn) analyses]. They are formed 
according to E1cB elimination reaction mechanism of 
α-deprotonation of poly(3-hydroxyalkanoate)s, in the in-
termolecular process. The process of carboxylate induced 
degradation of PHA is shown in Scheme A [9].
The unsaturated end groups can be subjected to subse-
quent modifications to obtain a wide variety of function-
al end groups, for instance hydroxyl, carboxyl or oxirane 
groups by oxidation of the above double bonds [10]. As 
example the synthesis of epoxy-functionalized oligo(3-hy-
droxybutyrate) (OHB) is presented in Scheme B.
Such unsaturated end groups of OHB may be also ozon-
olyzed to the aldehyde function and used as PHA-based 
carriers for drug delivery systems with pH-controlled re-
lease [11]. The example of such reaction can be synthesis of 
oligo(3-hydroxybutyrate) glyoxylate shown in Scheme C. 
The controlled molecular weight and the presence of 
double bonds and/or other functional groups as terminal 
groups make the above oligomers or polymers particu-
larly suitable as macromers (building blocks) for the syn-
thesis and/or modification of polymers, particularly of 
biodegradable polymers for medical applications [12]. It 
was also found that oligomers consisted of 3-hydroxybu-
tyrate 3-malic acid units can be synthesized via thermal 
treatment of poly(3-hydroxybutyrate) (PHB) in oxygen/
ozone mixture. Nuclear magnetic resonance (NMR) and 










POLIMERY 2017, 62, nr 4  319
multi-stage mass-spectrometry (MS) characterization re-
vealed random distribution of 3-malic acid units in oligo-
meric products as well as content of the malic acid units 
dependent on oxidation conditions [13]. 
PHA oligomers contained hydroxyl end groups 
A highly selective method for controlling the degra-
dation of PHA via a reduction reaction that uses lithi-
um borohydride was reported [14]. Using this method, 
oligo(hydroxyalkanoate)diols were obtained according 
reaction shown in Scheme D.
The structural characterization of the oligo(hydroxy-
alkanoate)diols was conducted using NMR and ESI-MSn 
analyses, which confirmed that oligomers were termi-
nated by two hydroxyl end groups. The reduction of the 
PHA occurred in a statistical way regardless of the chem-
ical structure of the comonomer units or of the micro-
structure of the polyester chain. This method can be used 
to synthesize various PHA oligodiols that are potentially 
useful in the further synthesis of tailor-made biodegrad-
able materials for medical applications. 
PHA bioactive oligomers 
The transesterification of PHA has been used as a tool 
for the preparation of delivery systems for selected bioac-
tive compounds containing either carboxyl or hydroxyl 
functionalities [15]. The first synthetic strategy was de-
signed for bioactive compounds within the carboxyl 
group, and these conjugates were obtained through the 
transesterification of natural PHA. Scheme E shows trans-
esterification reaction of PHA by (4-chloro-2-methyl - 
ph enoxy)acetic acid (MCPA).
The second synthetic strategy was selected for bioac-
tive compounds within the hydroxyl group [16]. The tyro-
sol-polymer conjugates were synthesized via transesteri-
fication reaction of tyrosol with selected PHA, presented 
in Scheme F.
The transesterification reaction of PHA with a bioactive 
compounds constitutes simple and economically favor-
able method for obtaining such conjugates. The bioactive 
PHA oligomers may be used in the area of controlled de-
livery systems in medicine, agrochemistry, in the cosmet-
ic industry, in household products and in coating systems. 
BIOACTIVE OLIGOMERS FROM SYNTHETIC 
ANALOGUES OF POLYHYDROXYALKANOATES 
Bioactive oligomers of PHB analogue 
Developed at our laboratories, and independently con-
firmed by Duda the anionic ring-opening polymerization 
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tool for the preparation of PHA analogues with the de-
sired molecular structure, including the structure of the 
end groups [17–19]. In contrast to unsubstantiated four 
membered β-propiolactone, β-butyrolactone (BL) is not 
polymerized by common anionic initiators. However, 
these initiators, when activated by the addition of mac-
rocyclic ligands such as crown ethers or cryptands, are 
able to initiate the polymerization of BL to PHB, i.e., the 
simplest PHA analogue [20, 21]. The same effect may be 
achieved by using bulky counterions or suitable highly 
polar aprotic solvents, e.g., DMSO [22, 23]. The polymer 
chain growth proceeds regioselectively and stereoselec-
tively entirely via carboxylate anions [24]. The anionic 
ROP reaction of BL to PHB is shown in Scheme G.
Propagation on carboxylate active centers (much less 
sensitive to impurities than any other anionic species) en-
ables the scaling up of the anionic ROP polymerization 
process [25, 26]. 
Also other catalysts were used for ROP reaction of BL, 
including discrete rare earth and cationic systems [27–30]. 
Synthetically prepared OHB were found to be nontoxic 
and they may be used as carriers covalently bounded to 
suitable bioactive compounds [31]. In our studies regard-
ing this area, several bioactive PHB oligomers suitable for 
medical, cosmetic, agrichemical and functional packag-
ing applications have been prepared and characterized 
at the molecular level using the ESI-MSn technique. The 
drug delivery systems were focused on penicillin G, ace-
tylsalicylic acid, and ibuprofen [32–34]. For perspective 
applications in cosmetology the OHB conjugates with 
α-lipoic acid (LA), p-coumaric acid, p-anisic acid (AA) 
and vanillic acid (VA) have been obtained and character-
ized [35, 36]. Synthetic pathway to OHB conjugate with 
selected antioxidants (AA and VA) is shown in Scheme H.
The bioconjugate hydrolytic degradation studies al-
lowed gaining thorough insight into the hydrolysis pro-
cess and confirmed the release of bioactive species. In 
vitro studies demonstrated that all of the conjugates stud-
ied were well tolerated by KB and HaCaT cell lines, as 
they had no marked cytotoxicity, while conjugates with 
a relatively short OHB carrier are optimal to support ke-
ratinocyte function [37]. 
For potential agricultural applications novel phenoxy-
carboxylic acid-OHB conjugates have been synthetized, 
and OHB conjugates with sorbic acid and benzoic acid, 
designed for food active packaging systems, have been 
also reported and the structures of the resulting conju-
gates have been established at the molecular level by elec-
trospray ionization multi-stage mass spectrometry [38]. 
The same strategy has also been applied for the synthe-
sis and characterization of a novel polypyrrole material 
grafted with biodegradable OHB pendants. The obtained 
OHB functionalized pyrroles were found to be promising 
candidates for the preparation of biodegradable conduc-
tive polymers [39, 40]. 
Bioactive oligomers of PHA analogues 
The specific synthetic method based on the carbony-
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sure opens up new opportunities for exploring the utility 
of β-lactones (and in particular precursors of synthetic an-
alogues of natural PHA, i.e., β-substituted β-lactones) as 
monomers for the synthesis of new polymers with desired 
properties. Thus, block and random synthetic PHA copo-
lymers were prepared by anionic ROP [41–43]. 
Incorporation of bioactive compounds into the β-lactones 
structure may lead to homo- and co-oligoesters with a bio-
active moiety covalently linked as pendent groups along 
an oligomer backbone. This synthetic strategy was applied 
by us for preparation of the PHA synthetic analogues with 
ibuprofen pendant groups [44], pesticide moieties [45] and 
recently antioxidants used in cosme tics [46]. The respec-
tive synthetic pathway, presented on Scheme I shows syn-
thesis of bioactive co-oligoesters via copolymerization of 
BL with β-substituted β-lactones containing covalently 
bonded selected bioactive moieties [e.g., ibuprofen, (4-chlo-
ro-2-methylphenoxy)acetic acid, and anisic acid].
Novel delivery systems obtained via the elaborated 
synthetic strategy contain a larger loading of biologically 
active substances per polymer macromolecule and their 
amount as well as position at the (co)polymer chain can 
be controlled. 
CONCLUSIONS
Biodegradable polymers have become materials of 
hope for the future and knowledge on the relationships 
between their structure, properties, and function is es-
sential for prospective safe applications of such materials 
in the areas of human health and the environment. 
When the development of biodegradable polymers 
was in its infancy the most crucial features were concen-
trated on the effect of macromolecular architecture, new 
monomer systems, polymerization mechanisms, and dif-
ferent polymerization techniques on final biodegradable 
properties. Significant efforts have been directed towards 
specific areas, such as mechanisms of biodegradation, 
biocompatibility and processing conditions. However, 
especially for potential applications in medicine such as-
pects like bio-safety of biodegradable polymers or nano-
-safety of their composites were and still are frequent-
ly neglected. The diverse applications of biodegradable 
polymers require case specific characterization and opti-
mization of the material properties, its preparation, pro-
cessing, and recycling. Pulling these different elements 
together under the common thread of forensic engineer-
ing of advanced polymeric materials (FEAPM) provides 
a central driving force for the otherwise disconnected 
works and constitutes the novelty of our recent research 
[47]. Such an approach helps to design novel biodegrad-
able polymeric materials and to avoid failures of the com-
mercial products manufactured from them. 
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